Kadmon Corporation - Company & Market Research Reports

Kadmon is a fully integrated biopharmaceutical company that focuses on small molecules and biologics to address disease areas of significant unmet medical need. The company is developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases. Its lead product candidates is KD025, a rho-associated coiled-coil kinase2 inhibitor, which is in Phase II clinical studies for the treatment of autoimmune, fibrotic, and neurodegenerative diseases. The company is headquartered in New York.

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018 - Product Thumbnail Image

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018

  • Report
  • 319 Pages
From
Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

  • Report
  • 344 Pages
From
Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2018 - Product Thumbnail Image

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2018

  • Report
  • 43 Pages
From
Immune Checkpoint Inhibitors: Clinical Trial Tracker - Product Thumbnail Image

Immune Checkpoint Inhibitors: Clinical Trial Tracker

  • Clinical Trials
From
Graft versus Host Disease (GvHD) - Market Insights, Epidemiology and Market Forecast - 2027 - Product Thumbnail Image

Graft versus Host Disease (GvHD) - Market Insights, Epidemiology and Market Forecast - 2027

  • Drug Pipelines
  • 222 Pages
From
Lupus Nephritis - Pipeline Review, H1 2015 - Product Thumbnail Image

Lupus Nephritis - Pipeline Review, H1 2015

  • Report
  • 108 Pages
From
Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2018 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2018

  • Report
  • 465 Pages
From
NASH Drugs Market, 2015 - 2025 - Product Thumbnail Image

NASH Drugs Market, 2015 - 2025

  • Report
  • 188 Pages
From
Psoriasis - Pipeline Review, H1 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H1 2018

  • Report
  • 709 Pages
From
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

  • Report
  • 294 Pages
From
Transplantation Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Transplantation Drug Development Pipeline Review, 2017

  • Report
  • 242 Pages
From
Global Lung Cancer Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Lung Cancer Therapeutics Market 2016-2020

  • Report
  • 101 Pages
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Report
  • 1051 Pages
From
Rheumatoid Arthritis - Pipeline Review, H1 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • Report
  • 1020 Pages
From
Ophthalmology Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Ophthalmology Drug Development Pipeline Review, 2016

  • Report
  • 633 Pages
From
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018

  • Report
  • 1759 Pages
From
Dermatology Therapeutics Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Dermatology Therapeutics Drug Development Pipeline Review, 2016

  • Report
  • 432 Pages
From
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016 - Product Thumbnail Image

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

  • Report
  • 420 Pages
From
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016

  • Report
  • 334 Pages
From
Non-Small Cell Lung Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H1 2018

  • Report
  • 3034 Pages
From
Loading Indicator
adroll